News & Press Releases

The Promise And Challenge Of Deploying AI In Clinical Trials

Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.

Share This Post

Pharmaceutical clinical trials present both a compelling and challenging use case for Artificial Intelligence. Look at one aspect of trials where the promise is clear – trials are packed with data, require extensive analysis and summarization, and operate in an industry where speed to market will give drugs longer times until patent expiry. However, data summarization needs to be error-free, complete, in exactly the right form, and thoroughly traceable in case questions arise.

Read the full article in Forbes. 

Scroll to Top